Caris Life Sciences, Inc. 8-K

What Happened

• On January 12, 2026, Caris Life Sciences, Inc. (CAI) issued a press release announcing preliminary unaudited financial results for the quarter and full year ended December 31, 2025 (press release furnished as Exhibit 99.1 to the Form 8‑K). The Company also announced it will post materials for its presentation at the 2026 J.P. Morgan Healthcare Conference on its investor relations website.

Key Details

• Filing date: January 12, 2026 (Form 8‑K, Items 2.02 and 7.01).
• Results covered: preliminary unaudited results for the quarter and full year ended December 31, 2025 (details presented in the press release, Exhibit 99.1).
• Investor materials: presentation slides for the 2026 J.P. Morgan Healthcare Conference to be posted at https://investor.carislifesciences.com.
• Legal note: the information and Exhibit 99.1 are furnished (not “filed”) under the Exchange Act and are not incorporated by reference into other filings.

Why It Matters

• This 8‑K gives investors an early, unaudited view of Caris’s latest quarterly and full‑year performance and signals what management will discuss at the J.P. Morgan conference. Because the results are preliminary and unaudited, final reported figures may change when audited results are released. The “furnished, not filed” status limits certain legal liabilities for the content.